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Survey Questions: 
A00a 
& 
A00b 
 /ŶĨĂŶƚ ?ƐŵŽŶƚŚĂŶĚǇĞĂƌŽĨďŝƌƚŚ 
 
 
 
 
A001-
A004 
Prevention If any one (or more) risk factor below is present this signifies high risk and need for 
aspirin 
 ?ŚǇƉĞƌƚĞŶƐŝǀĞĚŝƐĞĂƐĞ ?ŐĞƐƚĂƚŝŽŶĂůŚǇƉĞƌƚĞŶƐŝŽŶ ?ƉƌĞ-eclampsia) during a previous 
pregnancy 
 ?ĐŚƌŽŶŝĐŬŝĚŶĞǇĚŝƐĞĂƐĞ 
 ?ĂƵƚŽŝŵŵƵŶĞĚŝƐĞĂƐĞƐƵĐŚĂƐƐǇƐƚĞŵŝĐůƵƉƵƐĞƌǇƚŚĞŵĂƚŽƐŝƐŽƌĂŶƚŝƉŚŽƐƉŚŽůŝƉŝĚ
syndrome 
 ?ƚǇƉĞ ?ŽƌƚǇƉĞ ?ĚŝĂďĞƚĞƐ 
 ?ĐŚƌŽŶŝĐŚǇƉĞƌƚĞŶƐŝŽŶ ?
 
If any two moderate risk factors are present  this signifies moderate risk and need 
for aspirin 
 ?ĨŝƌƐƚƉƌĞŐŶĂŶĐǇ 
 ?ĂŐĞ ? ?ǇĞĂƌƐŽƌŽůĚĞƌ 
 ?ƉƌĞŐŶĂŶĐǇŝŶƚĞƌǀĂůŽĨŵŽƌĞƚŚĂŶ ? ?ǇĞĂƌƐ 
 ?ďŽĚǇŵĂƐƐŝŶĚĞǆ ?D/ ?ŽĨ ? ?ŬŐ ?ŵ ?ŽƌŵŽƌĞĂƚĨŝƌƐƚǀŝƐŝƚ 
 ?ĨĂŵŝůǇŚŝƐƚŽƌǇŽĨƉƌĞ-eclampsia 
 ?ŵƵůƚŝƉůĞƉƌĞŐŶĂŶĐǇ ? 
 
B001-
B003 
Surveillance  Hypertension that is present at the booking visit or before 20 weeks (140/90) or if the 
woman is taking antihypertensive medication when pregnancy is diagnosed. The 
raised BP can be primary or secondary to another condition. 
B001-
B003 
Surveillance ACE or ARBs are not recommended for use in pregnancy therefore alternatives  should be 
prescribed as soon as pregnancy is confirmed 
 
Angio converting enzyme (ACE) inhibitors 
Benazepril - Lotensin 
Captopril - Capoten 
Enalapril - Vasotec, Epaned 
Fosinopril - Monopril 
Lisinopril - Prinivil, Zestril 
Moexipril - Univasc 
Perindopril - Aceon 
Quinapril - Accupril 
Ramipril - Altace 
trandolapril - Mavik 
Angiotensin receptor blockers (ARBs)  
Candesartan - Amias 
Eprosartan - Teveten  
Irbesartan - Aprovel, CoAprovel  
Losartan - Cozaar, Cozaar Comp  
Olmesartan - Olmetec, Olmetec Plus  
Telmisartan - Micardis, Micardis Plus  
Valsartan - Diovan, Co-Diovan, Exforge 
B004-
B007 
Surveillance ZĞĨĞƌƐƚŽĞĂĐŚƐĞƉĂƌĂƚĞĂŶƚĞŶĂƚĂůǀŝƐŝƚƚŚĂƚŶĞĐĞƐƐŝƚĂƚĞƐĂŶ ‘ĂŶƚĞŶĂƚĂůĂƐƐĞƐƐŵĞŶƚ ? ?ŝƚ
could be that a woman was seen on the same day more than once, so each admission 
to the maternity assessment unit, each antenatal day unit visit or each community 
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clinic or a home visit, irrespective of the reason for the visit  
B008-
B009 
Surveillance If a woman with hypertension was seen within the maternity unit (secondary care 
facility) was there evidence that an initial automated reagent-strip reading device was 
used or evidence that a urine specimen was sent to the lab for protein: creatinine 
ratio (PCR) estimation for each antenatal visit/assessment 
 
(automated reagent  ?strip reading device use is not recommended for women seen in 
primary care facilities (GP surgeries for example) please do  not include assessments 
conducted in primary care in this section) 
 
If automated reagent-strip reading device showed equal to or more than +1 protein, 
was a urine sample sent to the biochemistry laboratory for protein: creatinine ratio 
(PCR) estimation 
C001 Diagnosis and 
treatment 
Is there evidence this woman had gestational hypertension (BP equal to or greater 
than 140/90 on two occasions at least 4 hours apart, this includes two readings at 
least 4 hours apart with a systolic BP equal to or greater than 140 with a normal 
diastolic or a diastolic equal to or greater than 90 with a normal systolic) with or 
without proteinuria  
C002 Diagnosis and 
treatment 
Did BP ever reach or exceed the  recommended treatment threshold 150/100 two 
occasions at least 4 hours apart 
C003 Diagnosis and 
treatment 
If this woman was diagnosed with gestational hypertension (irrespective of BP level), 
what treatment was started 
C004 Diagnosis and 
treatment 
If the women was diagnosed with gestational hypertension (irrespective of BP level), 
was proteinuria estimated at that time 
C005 Diagnosis and 
treatment 
If the woman had proteinuria (at the time her BP exceeded the threshold for 
treatment) what method was used to estimate the proteinuria (tick all that apply) 
C006 Diagnosis and 
treatment 
Was the woman ever admitted to hospital because of high blood pressure (antenatal 
admission only) 
C007-
C008 
Diagnosis and 
treatment 
If this woman was admitted to hospital because of high blood pressure antenatally, 
what was her highest blood pressure prior to admission (the highest diastolic and 
systolic readings may not be recorded together, i.e. may have occurred at different 
times) 
C008 Diagnosis and 
treatment 
If admitted to hospital antenatally, what was the protein estimation prior to 
admission 
C009 Diagnosis and 
treatment 
If admitted because of high blood pressure were antihypertensive medications 
prescribed 
C009 Diagnosis and 
treatment 
If antihypertensive medications were prescribed when admitted because of high 
blood pressure, which medication (s) was/were prescribed 
D001 Timing of birth Was early delivery (before 37 weeks) offered because of hypertension (induction or 
caesarean section) 
D002 Timing of birth If early birth offered (before 37 weeks) was BP generally above 160/110 
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D003 Timing of birth Was early delivery (after 37 weeks) offered because of hypertension (induction or 
caesarean section) 
D004 Timing of birth If early birth offered (after 37 weeks) was BP generally above 160/110 
E001 Postnatal follow-
up 
If diagnosed with hypertension or pre-eclampsia, was there any evidence that future 
risk of gestational hypertension and pre-eclampsia was discussed 
E002 Postnatal follow-
up 
Was there any evidence that a postnatal review appointment was given 
E003 Postnatal follow-
up 
If there was evidence that the woman attended a postnatal review (6 ?8 weeks after 
the birth) was a medical review within that appointment recorded 
